Delivery Order SPE2DB22D3011-SPE2DB25FQ0MP

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order valued at $20,326.82 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Nurtec ODT 75 mg tablets, a neurological medication, with a completion date of May 2, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $10,884.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a prescription medication, and has an ultimate completion date of April 18, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award, valued at $11,767.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a prescription medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,899.42 delivery order contract is for the provision of Nurtec ODT 75 mg tablets and has an ultimate completion date of April 11, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,578.99 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 27, 2023, with a completion date of July 28, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $7,967.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA, Defense...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order with a firm fixed price. The award has a ceiling value of $8,291.85 and is set to expire on January 12, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA...
This federal contract award is a $2,598.08 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 MG tablets. It is a firm-fixed-price contract with an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This federal contract award, valued at $8,129.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, is for the supply of Nurtec ODT 75 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,008.04 Delivery Order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Firm Fixed Price arrangement with a completion date of May 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FQ0MP
    Delivery Order

This federal contract award, valued at $8,100.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Nurtec ODT 75 mg tablets, a neurological medication, with a performance period extending through April 2025.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle for the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies. The contract does not have a set-aside designation, indicating open competition. This delivery order is one of many that Amerisourcebergen fulfills under the IDC to supply a wide range of pharmaceutical products and medical supplies to support federal, particularly military and veteran, healthcare programs.

Generated 7/22/25, 10:03 AM